Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Patrocinados

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Posted

118

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Please log in to like, share and comment!

Ruling party lawmakers slam government performance

KATHMANDU: Dissatisfaction with the performance of the ruling coalition government, led by the...

By 0 5

Mrunal Thakur: Linked to Dhanush, has Rs 33 crore net worth

Mrunal Thakur is currently garnering attention for her role in 'Son of Sardaar 2' and rumored...

By 0 27

Evening news wrap: 11 jawans missing in Uttarakhand flash floods; PM Modi inaugurates Kartavya Bhawan and more

By 0 36

Explained: Why Stanford is shutting down its inclusion office, and what it means for US campuses

By 0 35

Maoist leaders seek to reconcile with Biplav after his move to form separate front

KATHMANDU: The much-anticipated unification process between the CPN (Maoist Centre) and the Netra...

By 0 59